FG
ARGS

Formula Growth’s Argos Therapeutics, Inc. ARGS Stock Holding History

Formula Growth’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,500
Closed -$162K – 191
2015
Q4 		$162K Buy
+3,500
New +$296K 0.04% 163

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Formula Growth's ARGS Position: Q1 2016 in Review

Formula Growth sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2016, closing a stake of 3,500 shares — an estimated $162K sold.

Formula Growth first reported a position in ARGS in Q4 2015 and held it in 1 quarter. The position peaked at $162K in Q4 2015. 21 funds tracked by Wall St. Rank hold ARGS as of Q1 2016.

  • Formula Growth reported no remaining Argos Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Formula Growth sold 3,500 Argos Therapeutics, Inc. shares in Q1 2016, an estimated $162K.
  • Formula Growth first reported a position in Argos Therapeutics, Inc. in Q4 2015 and held it in 1 quarter.
  • Formula Growth's Argos Therapeutics, Inc. position peaked at $162K in Q4 2015.
  • 21 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2016.

Based on Formula Growth's 13F filing for Q1 2016, filed 15 Aug 2016.